1. Home
  2. WES vs VTRS Comparison

WES vs VTRS Comparison

Compare WES & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Midstream Partners LP Common Units Representing Limited Partner Interests

WES

Western Midstream Partners LP Common Units Representing Limited Partner Interests

HOLD

Current Price

$39.46

Market Cap

15.0B

Sector

Utilities

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$10.66

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WES
VTRS
Founded
2007
1961
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Medicinal Chemicals and Botanical Products
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.0B
12.0B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
WES
VTRS
Price
$39.46
$10.66
Analyst Decision
Hold
Hold
Analyst Count
5
6
Target Price
$41.20
$11.17
AVG Volume (30 Days)
1.5M
9.6M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
9.26%
4.49%
EPS Growth
N/A
N/A
EPS
3.38
N/A
Revenue
$3,740,425,000.00
$14,124,400,000.00
Revenue This Year
$7.07
N/A
Revenue Next Year
$7.20
$1.61
P/E Ratio
$11.63
N/A
Revenue Growth
5.81
N/A
52 Week Low
$33.60
$6.85
52 Week High
$43.33
$13.25

Technical Indicators

Market Signals
Indicator
WES
VTRS
Relative Strength Index (RSI) 59.77 54.95
Support Level $38.60 $10.49
Resistance Level $39.30 $10.73
Average True Range (ATR) 0.63 0.32
MACD 0.04 -0.02
Stochastic Oscillator 77.31 53.28

Price Performance

Historical Comparison
WES
VTRS

About WES Western Midstream Partners LP Common Units Representing Limited Partner Interests

Western Midstream Partners LP is a USA-based company which own, operate, acquire and develop midstream energy assets. The company through its subsidiary is engaged in the business of gathering, processing, compressing, treating and transporting natural gas, condensate, NGLs and crude oil. It owns or has investments in assets located in the Rocky Mountains (Colorado, Utah, and Wyoming), the Mid-Continent (Kansas and Oklahoma), North-central Pennsylvania and Texas.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: